Form 8-K - Current report:
SEC Accession No. 0001193125-23-111671
Filing Date
2023-04-24
Accepted
2023-04-24 06:08:00
Documents
12
Period of Report
2023-04-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d258607d8k.htm   iXBRL 8-K 48405
  Complete submission text file 0001193125-23-111671.txt   179409

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA idya-20230423.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20230423_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20230423_pre.xml EX-101.PRE 11712
6 EXTRACTED XBRL INSTANCE DOCUMENT d258607d8k_htm.xml XML 3482
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 23837849
SIC: 2834 Pharmaceutical Preparations